Floatz logo

PREDNISONE TABLETS

Thalassemia

Memorial Sloan Kettering Cancer CenterSmall moleculePhase 2Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
89/ 100

Competitive context

21 Active assets in the Thalassemia cohort.

Asset / SponsorPhaseRating
Deferasirox
Novartis Pharmaceuticals
Phase 4BBB
Hydroxyurea
Riphah International University
Phase 4BB
Fludarabine
Memorial Sloan Kettering Cancer Center
Phase 2/3BB
Conjugated Pneumococcal Vaccine
Fakultas Kedokteran Universitas Indonesia
Phase 4BB
Busulphan
University of California, San Francisco
Phase 2/3BB

View all 50 →

Same molecule, other indications

PREDNISONE TABLETS is also rated in:

Recurrent Adult T-cell Leukemia/LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
diffuse large B-cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →